Brought to you by:
One-year results from IVC stent clinical trial show positive safety and efficacy data
Twelve-month results from the clinical trial assessing a dedicated venous stent for the treatment of symptomatic inferior vena cava (IVC) obstruction with or without combined iliofemoral obstruction showed the device exceeded its performance goal for freedom from a composite of…
When to re-intervene: Stent surveillance and the effective use of RevCore mechanical thrombectomy to clear in-stent thrombosis
This advertorial is sponsored by Stryker/Inari Medical. How a finely tuned stent surveillance program plays a crucial role in raising the alarm of worsening symptoms in DVT patients and identifies those who might require reintervention with mechanical thrombectomy. For Jake…
AVF 2025: A call for ‘second-generation steps’ in venous stenting
The need for a revolutionary second generation of venous stents are among the gaps and unmet needs currently at play in deep venous surgery, the 2025 American Venous Forum (AVF), held from Feb. 16–19 in Atlanta, Georgia, heard. Erin Murphy…
Prognostic tool for CVO stenting set to enhance therapeutic decision-making and scientific reporting
With the aims of predicting and comparing venous stent outcomes, aiding in communication with patients, and enhancing therapeutic decision-making, researchers have proposed an anatomical classification system for patients with chronic venous obstruction (CVO) of the iliofemoral tract undergoing interventional procedures.…
Study highlights declining venous stent patency rates after one year
A systematic review and meta-analysis of over 1,500 venous stenting procedures—said to be the first study on this topic to date—has highlighted an 18% drop in primary patency rates after one-year follow-up with declining rates beyond 12 months. As a…
Venous VQI celebrates decade milestone
At the recent VEITHsymposium (Nov. 19–23) in New York City, Marc Passman, MD, reflected on the achievements of the Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) venous arm, in collaboration with the American Venous Forum (AVF), since its…
ABRE subanalysis highlights obesity ‘paradox’ in post-venous stenting outcomes
Results from a subset analysis of the ABRE study have shown that patients in three out of the six World Health Organisation (WHO) body mass index (BMI) groups—‘pre-obesity’, ‘obesity class I’ and ‘obesity class II’—trended towards higher 36-month patency rates…
First post-FDA approval implant of Duo venous stent system announced
Royal Philips today announced the first implant of the Duo venous stent system, indicated to treat symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI), following premarket approval (PMA) from the Food and Drug Association (FDA). On June…
Longer fasting before venography appears to impact stent size selection, new study finds
During the 2024 American Venous Forum (AVF) annual meeting in Tampa, Florida (March 3–6), Kurt S. Schultz, MD, a general surgery resident at the Yale University School of Medicine in New Haven, Connecticut, presented data from a study exploring how…
Venous stenting and the IVC: ‘Persistent problems’ in the setting of post-thrombotic syndrome
The question of “persistent problems” with venous stenting among post-thrombotic syndrome (PTS) patients emerged as a key talking point during the recent Deep Venous Stenting Summit that took place during VAM 2023 in National Harbor, Maryland (June 14–17). The issue…